Chronic mucocutaneous candidiasis: model-building in cellular immunity.
D000293:Adolescent; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D001323:Autoantibodies; D001803:Blood Transfusion; D002177:Candidiasis / Q000188:drug therapy; D002179:Candidiasis, Cutaneous / Q000150:complications / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D002648:Child; D004700:Endocrine System Diseases / Q000150:complications; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy / Q000276:immunology; D006229:Hand Dermatoses / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D008297:Male; D009092:Mucous Membrane; D009262:Nails; D012867:Skin / Q000473:pathology
D001323:Autoantibodies; D000666:Amphotericin B